STOCK TITAN

VEON’s Kyivstar Expands Digital Healthcare Services in Ukraine with Tabletki.ua Acquisition

(Moderate)
(Neutral)

VEON (Nasdaq: VEON) announced that subsidiary Kyivstar completed acquisition of 100% of Tabletki.ua for USD 160 million, payable in Ukrainian hryvnia. Tabletki.ua partners with over 14,000 pharmacies, averaged 14 million reservations/month in 2025, and reported LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of Sept 30, 2025, implying a price to LTM earnings ratio of 8.0X. The acquisition expands Kyivstar’s digital healthcare ecosystem alongside Helsi and other Kyivstar services.

Loading...
Loading translation...

Positive

  • Acquisition value of USD 160 million for 100% ownership
  • Tabletki.ua averaged 14 million reservations per month in 2025
  • Platform GMV reached UAH 57.3 billion (LTM to Sept 30, 2025)
  • LTM EBITDA of USD 24 million and LTM net profit of USD 20 million, price/earnings 8.0X

Negative

  • None.

News Market Reaction – VEON

+0.91%
+0.91% Session close to close

In the Feb 10 session, VEON gained 0.91%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement extends VEON’s digital-operator strategy by adding Tabletki.ua’s healthcare market...
Analysis

This announcement extends VEON’s digital-operator strategy by adding Tabletki.ua’s healthcare marketplace to Kyivstar’s Ukrainian ecosystem. The platform’s 14 million monthly reservations, LTM GMV of UAH 57.3 billion, and LTM net profit of USD 20 million highlight established scale. Historically, acquisition news for VEON has produced modest or negative next-day moves on average, underscoring the importance of monitoring integration progress, execution in Ukraine, and subsequent financial disclosures.

Key Figures

Acquisition price: USD 160 million Partner pharmacies: 14,000+ pharmacies Monthly reservations: 14 million per month +5 more
8 metrics
Acquisition price USD 160 million Consideration for 100% of Tabletki.ua, payable in Ukrainian hryvna
Partner pharmacies 14,000+ pharmacies Pharmacies across Ukraine partnered with Tabletki.ua
Monthly reservations 14 million per month Average reservations facilitated in 2025
GMV FY2024 UAH 45 billion (USD 1.06 billion) Gross merchandise value of bookings via Tabletki.ua in FY2024
GMV LTM UAH 57.3 billion (USD 1.19 billion) GMV for LTM ending September 30, 2025
LTM EBITDA USD 24 million Tabletki.ua unaudited LTM EBITDA as of September 30, 2025
LTM net profit USD 20 million Tabletki.ua unaudited LTM net profit as of September 30, 2025
Price-to-earnings 8.0x Acquisition price to LTM earnings multiple for Tabletki.ua

Previous Acquisition Reports

4 past events · Latest: Dec 16 (Positive)
Same Type Pattern 4 events
Date Event Sentiment 24h Move Catalyst
Dec 16 Energy acquisition Positive +1.4% Kyivstar acquired SUNVIN 11 adding 12.9 MW of solar capacity in Ukraine.
Oct 21 Digital acquisition Positive -3.3% Beeline Kazakhstan agreed to acquire OLX Kazakhstan online classifieds business.
Mar 19 Ride-hailing deal Positive -0.1% Kyivstar moved to buy 97% of Uklon, Ukraine’s top ride-hailing platform.
Nov 20 Spectrum purchase Positive -2.1% Kyivstar invested UAH 1.43B to acquire additional mobile spectrum in Ukraine.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Across recent acquisition headlines, VEON often saw flat-to-negative next-day moves, with only one of four events posting a clearly positive reaction despite strategically aligned deals.

Recent Company History

Over the past year, VEON has used acquisitions to deepen Kyivstar’s role in Ukraine and broaden its digital operator strategy. Deals included solar capacity via SUNVIN 11 on Dec 16, 2025, OLX Kazakhstan’s classifieds platform on Oct 21, 2025, Uklon ride-hailing on Mar 19, 2025, and spectrum purchases on Nov 20, 2024. These supported energy resilience, digital services, and network capacity. Today’s Tabletki.ua deal extends the same playbook into digital healthcare.

Key Terms

gross merchandise value, ebitda
2 terms
gross merchandise value financial
"Gross merchandise value (GMV) of bookings via the platform reached UAH 45 billion"
Total dollar value of all goods and services sold through a marketplace or e-commerce platform during a set period, before deducting fees, returns or costs. Think of it as the total amount rung up at the register across an entire shopping mall: it shows the platform’s sales volume and user activity. Investors watch it to gauge growth and marketplace traction, but must pair it with metrics like revenue share and margins to assess profitability.
ebitda financial
"Based on unaudited management accounts, Tabletki.ua generated LTM EBITDA of USD 24 million"
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.
View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Dubai, Kyiv and New York, February 10, 2026 VEON Ltd. (Nasdaq: VEON) (“VEON”), a global digital operator, announces that today its subsidiary Kyivstar Group Ltd. (“Kyivstar”) (Nasdaq: KYIV; KYIVW) signed a definitive agreement and completed the transaction to acquire 100% of Tabletki.ua for USD 160 million, payable in Ukrainian hryvna in Ukraine. Tabletki.ua is one of Ukraine’s most widely used digital platforms for finding, comparing and reserving medicines and other products available at Ukrainian pharmacies.

Tabletki.ua is trusted by millions of users every month and is Ukraine’s preferred digital platform for accessing prescriptions as well as other medicinal and nutritional health products. The platform enables customers to quickly find, compare, and reserve prescribed and over-the-counter medicines and healthcare products available at pharmacies nationwide, ensuring availability, transparent pricing, and convenient access to essential healthcare products.

Tabletki.ua partners with more than 14,000 pharmacies across Ukraine and facilitated an average of 14 million reservations per month in 2025, reflecting its role as an everyday healthcare tool for Ukrainian families. Gross merchandise value (GMV) of bookings via the platform reached UAH 45 billion (USD 1.06 billion) in FY2024 and UAH 57.3 billion (USD 1.19 billion) for the last twelve months ending September 30, 2025.

The acquisition strengthens Kyivstar’s growing healthcare ecosystem, complementing its earlier acquisition of the digital healthcare platform Helsi in 2022. Tabletki.ua will become part of Kyivstar’s expanding portfolio of digital services, which also includes ride-hailing and delivery platform Uklon, Kyivstar TV, and the MyKyivstar super-app.

“Ukrainian businesses like Tabletki.ua are enabling millions of Ukrainians to benefit from convenient, digital-first solutions, supporting the growth and resilience of the country,” said Oleksander Komarov, President of Kyivstar. “Tabletki.ua already plays an essential role in everyday life for millions of Ukrainians. By combining Kyivstar’s experience in building and scaling digital platforms with Tabletki.ua’s strong market position, we will make healthcare services even more accessible and convenient across Ukraine.”

“This acquisition strengthens our commitment to Ukraine by expanding access to digital healthcare solutions that improve everyday life,” said Kaan Terzioglu, VEON Group CEO and Executive Chairman of Kyivstar. “Together, Kyivstar and Tabletki.ua will accelerate the development of innovative, customer-focused healthcare services.”

Based on unaudited management accounts, Tabletki.ua generated LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of September 30, 2025. The agreed consideration of USD 160 million corresponds to a price to LTM earnings ratio of 8.0X.

Today, VEON also published a presentation for investors that provides further information about Tabletki.ua and the strategic rationale for the acquisition. The presentation is available on the VEON website here.

About Kyivstar Group Ltd.
Kyivstar Group Ltd. (“Kyivstar”) is a Nasdaq-listed holding company that operates JSC Kyivstar, Ukraine’s leading digital operator and the first Ukrainian company to list on a U.S. stock exchange. Kyivstar’s companies provide a broad range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as Big Data, cloud, and cybersecurity.

Together with VEON, Kyivstar intends to invest USD 1 billion in Ukraine between 2023-2027, through investments in infrastructure, technological development and strategic acquisitions, as well as charitable donations for social projects.

For more information, please visit https://investors.kyivstar.ua.  

Nasdaq tickers: KYIV; KYIVW

About VEON
VEON is a digital operator that provides connectivity and digital services to nearly 150 million connectivity customers and over 140 million digital users. Operating across five countries that are home to more than 6% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information, visit: www.veon.com

Forward-Looking Statements
This release contains “forward-looking statements”, within the meaning of the Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for VEON, and the expected financial performance of VEON post the acquisition. There are numerous risks, uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, including risks relating the closing of Kyivstar’s acquisition of Tabletki.ua, the expected impact of the acquisition for VEON, the expected financial performance of VEON post the acquisition, as well as VEON’s ability to achieve anticipated results and business objectives, among others discussed in the section entitled “Risk Factors” in VEON’s 2024 Form 20-F filed with the SEC on April 25, 2025 and other public filings made by VEON with the SEC. The forward-looking statements contained herein speak only as of the date of this release and VEON disclaims any obligation to update them, except as required by law. VEON disclaims any obligation to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.

Additionally, this press release includes certain financial information and data of Tabletki.ua derived from preliminary, unaudited management accounts as of the dates indicated and is subject to completion of customary financial closing, review, and audit procedures. This information is provided for informational purposes only and should not be regarded as a complete statement of financial results or relied upon as necessarily indicative of historical or future performance.

Contact Information

VEON 
Hande Asik
Chief Communications and Strategy Officer
pr@veon.com


FAQ

What did VEON announce about the Tabletki.ua acquisition (VEON) on February 10, 2026?

VEON announced Kyivstar completed acquisition of 100% of Tabletki.ua for USD 160 million. According to VEON, the deal adds a leading digital pharmacy platform to Kyivstar’s healthcare ecosystem, integrating Tabletki.ua with Helsi and other Kyivstar digital services.

How large is Tabletki.ua’s platform and usage that VEON paid for (VEON)?

Tabletki.ua partners with over 14,000 pharmacies and averaged 14 million reservations per month in 2025. According to VEON, the platform generated GMV of UAH 57.3 billion for the twelve months to Sept 30, 2025.

What financial metrics did VEON report for Tabletki.ua (VEON) in the acquisition?

Based on unaudited management accounts, Tabletki.ua had LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of Sept 30, 2025. According to VEON, the agreed consideration implies a 8.0X price to LTM earnings ratio.

How will the Tabletki.ua acquisition affect Kyivstar’s digital services portfolio (VEON)?

The acquisition adds a national digital pharmacy platform to Kyivstar’s offerings, expanding healthcare capabilities across Ukraine. According to Kyivstar, Tabletki.ua will integrate with Helsi, MyKyivstar, Uklon and other services to broaden digital healthcare access.